Efficacy and Safety of Once-Daily Ciprodexa Otic Foam Compared to Twice-daily Ciprodex Ear Drops in Acute Otitis Externa

PHASE2CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

October 31, 2011

Study Completion Date

November 30, 2011

Conditions
Otitis ExternaOtorhinolaryngologic DiseasesEar DiseasesOtitis
Interventions
DRUG

Ciprodex Otic Suspension

4 gtt b.i.d. for 7 days.

DRUG

Ciprodexa Otic Foam

0.3% Ciprofloxacin, 0.1% Dexamethasone Otic Foam, 1 actuation, q.d. for 7 days

Trial Locations (7)

58100

Wolfson Medical Center, Holon

Unknown

Meir Medical Center, Kfar Saba

HaEmek Medical Center, Afula

Soroka Medical Center, Beersheba

Clalit Health Services - Raziel Clinic, Netanya

Maccabi Healthcare Services (H.M.O.), Tel Aviv

Sourasky Medical Center (Ichilov), Tel Aviv

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Otic Pharma

INDUSTRY